Xi Jin
机构：Beijing Normal University · ORCID：0000-0003-2624-1323
发表论文 181 篇 · 总被引 4065 次 · h-index 35
代表论文
- Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial (2025 · Cancer Cell · 被引 4)
- Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial) (2025 · Molecular Cancer · 被引 2)
- NAD + ‐Dependent Enzyme SIRT3 Limits Intestinal Epithelial Cell Functions Through NAD + Synthesis Pathway in Colorectal Cancer (2026 · Advanced Science · 被引 1)
- Landscape of gene fusions in hormone receptor-positive breast cancer reveals ADK fusions as drivers of progression and potential therapeutic targets (2025 · Cell Discovery · 被引 1)
- Table S1 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies (2026)
- Figure S5 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies (2026)